Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4661Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis0.5 MOI30% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4662Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineCAL27NANAStatistical analysis1 MOI30% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4663Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis0.001 MOI82% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4664Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis0.005 MOI60% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4665Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis0.01 MOI55% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4666Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis0.05 MOI40% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4667Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis0.1 MOI38% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4668Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis0.5 MOI38% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4669Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-47NANAStatistical analysis1 MOI30% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4670Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis0.001 MOI100% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4671Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis0.005 MOI95% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4672Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis0.01 MOI90% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4673Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis0.05 MOI40% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4674Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis0.1 MOI25% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4675Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis0.5 MOI22% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4676Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUD-SCC-2NANAStatistical analysis1 MOI20% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4677Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis0.001 MOI90% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4678Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis0.005 MOI70% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4679Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis0.01 MOI65% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4680Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis0.05 MOI50% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4681Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis0.1 MOI40% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4682Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis0.5 MOI38% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4683Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-74ANANAStatistical analysis1 MOI38% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4684Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis0.001 MOI90% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4685Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis0.005 MOI82% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4686Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis0.01 MOI60% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4687Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis0.05 MOI60% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4688Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis0.1 MOI50% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4689Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis0.5 MOI40% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4690Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-1NANAStatistical analysis1 MOI38% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4691Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis0.001 MOI90% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4692Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis0.005 MOI82% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4693Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis0.01 MOI76% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4694Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis0.05 MOI62% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4695Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis0.1 MOI62% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4696Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis0.5 MOI50% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4697Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNAHuman squamous cell carcinoma cell lineUM-SCC-11ANANAStatistical analysis1 MOI40% cell viability after 2 daysNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4698Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusYesNoNoNANANANANANANANAAthymic nude mice subcutaneous xenograft for CAL27 (1.5E+7)2.0E+6 pfu on day 7 and 16NA Mice treated with virus shows delayed tumor growth compared to control, one shows complete tumor regressionIntratumoralNAInduce antitumor immune responseNA27119105
OV_4699Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergyNoNAHuman squamous cell carcinoma cell lineSCC-74ANANACrystal violet staining0.5 MOI38% cell viabilityNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4700Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergyNoNAHuman squamous cell carcinoma cell lineCAL27NANACrystal violet staining0.5 MOI42% cell viabilityNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4701Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergyNoNAHuman squamous cell carcinoma cell lineSCC-1NANACrystal violet staining0.5 MOI40% cell viabilityNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4702Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergyNoNAHuman squamous cell carcinoma cell lineSCC-2NANACrystal violet staining0.5 MOI45% cell viabilityNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4703Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergyNoNAHuman squamous cell carcinoma cell lineSCC-11ANANACrystal violet staining0.5 MOI38% cell viabilityNoNoNA No responseNANAInduce antitumor immune responseNA27119105
OV_4704Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (0.7 mg/kg/day) an copper chelator showing synergistic effectNoNANANANANANANANAAthymic nude mice xenograft for UM-SCC-74A (1.5E+7)2.0E+6 pfu on day 7NA Increased in survival time and reduction in tumor volume to below 200 cubic mm comapred to control 700 cubic mmIntratumoralNAInduce antitumor immune responseNA27119105
OV_4705Herpes simplex virusRAMBODNAHerpesviridaeAntiangiogenic Vstat120 expressing virusNoVirus combination with ATN-224 (0.7 mg/kg/day) an copper chelator showing synergistic effectNoNANANANANANANANAAthymic nude mice xenograft for CAL27 (1.5E+7)2.0E+6 pfu on day 7NA Increased in survival time and reduction in tumor volume to below 500 cubic mm comapred to control 2000 cubic mmIntratumoralNAInduce antitumor immune responseNA27119105
OV_5188Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCCHuman rhabdosarcoma cell lineRD1.5E+3 cells per wellNAAlamar blue assay0.1 PFU100% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5189Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCCHuman rhabdosarcoma cell lineRD1.5E+3 cells per wellNAAlamar blue assay1 PFU50% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5190Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCCHuman rhabdosarcoma cell lineRD1.5E+3 cells per wellNAAlamar blue assay10 PFU10% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5191Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCCHuman rhabdosarcoma cell lineRD1.5E+3 cells per wellNAAlamar blue assay20 PFU5% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5192Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCChuman cellosaurus cell lineSJC RH301.5E+3 cells per wellNAAlamar blue assay0.1 PFU90% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5193Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCChuman cellosaurus cell lineSJC RH301.5E+3 cells per wellNAAlamar blue assay1 PFU90% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5194Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCChuman cellosaurus cell lineSJC RH301.5E+3 cells per wellNAAlamar blue assay10 PFU30% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5195Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copis of gamma 34.5 geneYesNoNoATCChuman cellosaurus cell lineSJC RH301.5E+3 cells per wellNAAlamar blue assay20 PFU22% cell viable after 72 hoursNoNoNA No responseNAInduction of apoptosisNANA27751346
OV_5256Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay0.1 PFU100% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5257Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay0.33 PFU70% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5258Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay1 PFU15% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5259Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay3.3 PFU5% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5260Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay10 PFU7% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5261Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay33 PFU1% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5262Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineSTOSE4000 cells per wellNAAlamar blue assay100 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5263Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay0.1 PFU100% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5264Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay0.33 PFU70% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5265Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay1 PFU50% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5266Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay3.3 PFU30% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5267Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay10 PFU10% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5268Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay33 PFU1% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5269Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineID84000 cells per wellNAAlamar blue assay100 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5270Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay0.1 PFU100% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5271Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay0.33 PFU70% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5272Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay1 PFU58% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5273Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay3.3 PFU30% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5274Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay10 PFU15% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5275Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay33 PFU1% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5276Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineIg104000 cells per wellNAAlamar blue assay100 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5277Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay0.1 PFU85% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5278Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay0.33 PFU87% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5279Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay1 PFU87% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5280Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay3.3 PFU78% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5281Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay10 PFU62% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5282Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay33 PFU22% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5283Herpes simplex virusM002DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 geneYesNoVirus expressing murine IL-12NAMurine ovarian adenocarcinoma cell lineMISIIR4000 cells per wellNAAlamar blue assay100 PFU20% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5284Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay0.1 PFU85% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5285Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay0.33 PFU70% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5286Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay1 PFU42% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5287Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay3.3 PFU10% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5288Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay10 PFU5% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5289Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay33 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5290Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineA27804000 cells per wellNAAlamar blue assay100 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5291Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay0.1 PFU100% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5292Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay0.33 PFU98% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5293Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay1 PFU95% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5294Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay3.3 PFU77% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5295Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay10 PFU60% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5296Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay33 PFU39% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5297Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHeyA84000 cells per wellNAAlamar blue assay100 PFU22% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5298Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHEYA8 MDR4000 cells per wellNAAlamar blue assay0.1 PFU100% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5299Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHEYA8 MDR4000 cells per wellNAAlamar blue assay0.33 PFU38% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5300Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHEYA8 MDR4000 cells per wellNAAlamar blue assay1 PFU10% cell viableNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5301Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHEYA8 MDR4000 cells per wellNAAlamar blue assay3.3 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340
OV_5302Herpes simplex virusM032DNAHerpesviridaeDeletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 geneYesNoVirus expressing murine IL-12NAHuman ovarian cancer cell lineHEYA8 MDR4000 cells per wellNAAlamar blue assay10 PFU100% cell killingNoNoNA No responseNANATumor specific T cell response inducedNA27784340